SC
RXRX icon

Syon Capital’s Recursion Pharmaceuticals RXRX Stock Holding History

Syon Capital’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.7K Buy
+10,970
New +$42.4K ﹤0.01% 904
2025
Q2 		– Sell
-22,150
Closed -$117K – 777
2025
Q1 		$117K Sell
22,150
-1,306
-6% -$9.52K 0.01% 569
2024
Q4 		$159K Buy
+23,456
New +$158K 0.01% 535

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Syon Capital's RXRX Position: Q1 2026 in Review

Syon Capital opened a new position in Recursion Pharmaceuticals (RXRX) in Q1 2026: 10,970 shares worth $33.7K. The stake represents ﹤0.01% of the portfolio and ranks #904 among its holdings. This is a return to the name: Syon Capital previously reported a position in RXRX as recently as Q1 2025.

Syon Capital first reported a position in RXRX in Q4 2024 and has held it in 3 quarters since. The position peaked at $159K in Q4 2024. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Syon Capital held 10,970 shares of Recursion Pharmaceuticals worth $33.7K as of Q1 2026.
  • Recursion Pharmaceuticals was a new Syon Capital position in Q1 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of Syon Capital's portfolio in Q1 2026, its #904 holding.
  • Syon Capital first reported a position in Recursion Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • Syon Capital's Recursion Pharmaceuticals position peaked at $159K in Q4 2024.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.